By AHRQ; Wednesday, May 18, 2011

Agency for Healthcare Research and Quality (AHRQ) Releases a New Report on Hip Fracture Pain and Management

HHS' Agency for Healthcare Research and Quality (AHRQ) would like to make you aware of a new report on hip fracture pain and management. This new Federal report concludes most treatments to relieve pain for patients who suffer a broken hip work at least in the short term, but finds a lack of evidence supporting one treatment over another. In addition, the report highlights an overall lack of high-quality data and evidence.

AHRQ has also released a clinician guide and companion consumer guide explaining hip fractures and summarizing the available treatment options. These guides are available online and may also be ordered from AHRQ's Clearinghouse by calling 800-358-9295 (please reference the code "C-02" when ordering). 

These guides are based on the report, Comparative Effectiveness of Pain Management Interventions for Hip Fracture, prepared by researchers at the University of Alberta Evidence-based Practice Center and supported by AHRQ. The research covered the following interventions: systemic analgesia, anesthesia, complementary and alternative medicine, multimodal pain management, nerve blocks, neurostimulation, rehabilitation and traction.

Key findings include:

  • Most interventions result in improvements in short-term, patient-reported pain scores; however, there were few differences in long-term clinical importance when comparisons between interventions are available.
  • Complication rates were generally low and the majority of complications were not significantly different among the interventions.
  • In the absence of notable difference in treatment effectiveness and safety, pain management in hip fracture patients relies heavily on available treatments, including staff skills and training, and patients' pre-existing conditions.
  • More research is needed to determine the relative effectiveness of pain interventions for hip fracture patients, including multi-center research studies and standardization of outcomes and methods.
  • We also hope you will take a moment to visit the Effective Health Care Program website http://www.effectivehealthcare.ahrq.gov to learn more about AHRQ's patient-centered outcomes research, and download other materials. If you have any questions or need more information, please contact us at EHC_Outreach@ahrq.hhs.gov.

The Agency's Effective Health Care Program represents an important Federal effort to compare treatments for health conditions and make the findings public. The program is intended to help patients, doctors, nurses, pharmacists, and others choose the most effective treatments. Additional related resources from AHRQ include more consumer and clinician guides, including Osteoporosis Treatments That Help Prevent Broken Bones: A Guide for Women After Menopause and Fracture Prevention Treatments for Postmenopausal Women with Osteoporosis.

The latest

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.